基于证据的细胞病理学.

Same author

Moving the dial on diagnostics: an update from the Lancet Commission on diagnostics.

Lancet (London, England)·2025

Same author

A World Health Assembly resolution on diagnostics: what pathologists should know and do.

Histopathology·2024

Same author

A world health assembly resolution on diagnostics: implications for the ESCMID community.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2023

Same author

Improved pathology reporting in NAFLD/NASH for clinical trials.

Journal of clinical pathology·2021

Same author

The Lancet Commission on diagnostics: transforming access to diagnostics.

Lancet (London, England)·2021

Same author

A dream of spring - the Lancet Commission on diagnostics.

Histopathology·2019

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

相关实验视频

基于证据的细胞病理学.

相关概念视频

Moving the dial on diagnostics: an update from the Lancet Commission on diagnostics.

A World Health Assembly resolution on diagnostics: what pathologists should know and do.

A world health assembly resolution on diagnostics: implications for the ESCMID community.

Improved pathology reporting in NAFLD/NASH for clinical trials.

The Lancet Commission on diagnostics: transforming access to diagnostics.

A dream of spring - the Lancet Commission on diagnostics.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

相关实验视频

基于证据的细胞病理学.

相关概念视频

相关文章

Moving the dial on diagnostics: an update from the Lancet Commission on diagnostics.

A World Health Assembly resolution on diagnostics: what pathologists should know and do.

A world health assembly resolution on diagnostics: implications for the ESCMID community.

Improved pathology reporting in NAFLD/NASH for clinical trials.

The Lancet Commission on diagnostics: transforming access to diagnostics.

A dream of spring - the Lancet Commission on diagnostics.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.